RF
HCA icon

Robbins Farley’s HCA Healthcare HCA Stock Holding History

Robbins Farley’s Portfolio HCA Stock Details HCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.7M Buy
4,368
+361
+9% +$153K 0.65% 49
2026
Q1 		$1.9M Sell
4,007
-10
-0.2% -$5.03K 0.84% 46
2025
Q4 		$1.88M Sell
4,017
-1,217
-23% -$565K 0.85% 45
2025
Q3 		$2.23M Sell
5,234
-632
-11% -$245K 0.93% 42
2025
Q2 		$2.25M Sell
5,866
-61
-1% -$22K 1.05% 38
2025
Q1 		$2.05M Buy
5,927
+987
+20% +$317K 1.09% 42
2024
Q4 		$1.48M Buy
4,940
+234
+5% +$81.8K 0.71% 49
2024
Q3 		$1.91M Sell
4,706
-734
-13% -$269K 0.96% 43
2024
Q2 		$1.75M Buy
5,440
+256
+5% +$83.2K 0.93% 45
2024
Q1 		$1.73M Sell
5,184
-311
-6% -$95K 0.91% 46
2023
Q4 		$1.49M Buy
5,495
+712
+15% +$176K 0.89% 51
2023
Q3 		$1.18M Buy
4,783
+179
+4% +$49K 0.79% 49
2023
Q2 		$1.4M Buy
4,604
+4,579
+18,316% +$1.27M 0.97% 43
2023
Q1 		$6.59K Hold
25
– – ﹤0.01% 123
2022
Q4 		$6K Buy
+25
New +$5.6K ﹤0.01% 108

Other funds holding HCA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Robbins Farley's HCA Position: Q2 2026 in Review

Robbins Farley increased its HCA Healthcare (HCA) stake by 9% in Q2 2026, buying an estimated $153K and bringing the position to 4,368 shares worth $1.7M. The position accounts for 0.65% of the portfolio, ranked #49.

Robbins Farley first reported a position in HCA in Q4 2022 and has held it in 15 quarters since. The position peaked at $2.25M in Q2 2025. 1,339 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Robbins Farley held 4,368 shares of HCA Healthcare worth $1.7M as of Q2 2026.
  • Robbins Farley bought 361 HCA Healthcare shares in Q2 2026, an estimated $153K.
  • HCA Healthcare made up 0.65% of Robbins Farley's portfolio in Q2 2026, its #49 holding.
  • Robbins Farley first reported a position in HCA Healthcare in Q4 2022 and has held it in 15 quarters since.
  • Robbins Farley's HCA Healthcare position peaked at $2.25M in Q2 2025.
  • 1,339 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Robbins Farley's 13F filing for Q2 2026, filed 23 Jul 2026.